XNAS
DETX
Market cap4mUSD
Sep 29, Last price
2.14USD
1D
3.65%
1Q
-45.78%
IPO
-60.84%
Name
Evernorth Health Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established on June 8, 2012, and based in Wilmington, Massachusetts, Liberty Defense Holdings Ltd. is dedicated to bringing its innovative HEXWAVE system to market. This advanced 3D imaging technology is engineered to identify concealed threats. Furthermore, the company delivers comprehensive, multi-technology security solutions specifically tailored for detecting hidden weapons in bustling public spaces and critical sites like airports, stadiums, and schools, where enhanced security is paramount.
Key people
Adam Kautzner
President
Leslie Achter
Vice President And General Manager, Commercial Division
Jen Awsumb
Vice President, Channel & Consumer Solutions
Rick Battelle
Senior Director, Fraud Investigations
Mark Bini
Head of Growth & COOrdinated Care, Care Solutions, Evernorth Health Services
Kelcey Blair
Vice President, Clinical Solutions
Jim Blondin
Director, Product Management
Gail Bridges
Director, Specialty Clinical Products
Nicole Casey
Director, Market Strategy & Support
Celeste Player
Vice President And General Manager, Strategic Drug Sourcing And Contracting
Justine Sessions
Director, Corporate Communications
Stephanie Uder
Vice President And General Manager, Pbm And Supply Chain Product
Katie Walsh
Chief Operating Officer, Pharmacy Benefits Management
Nikki White
Vice President And General Manager, Health Plan, Regulated Markets, And Military Division
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
1 Express Way
Saint Louis, MO 63121
US
Saint Louis, MO 63121
US
Previous name
Express Scripts Holding Company
Previous name
Aristotle Holding, Inc.
Valuation
Title in thousands, except ratios and share amounts | FY | FY |
|---|---|---|
| 2017‑12 | 2016‑12 | |
| Income | ||
Revenues | ||
Cost of revenue | ||
Unusual Expense (Income) | ||
NOPBT | ||
NOPBT Margin | ||
Operating Taxes | ||
Tax Rate | ||
NOPAT | ||
Net income | ||
Dividends | ||
Dividend yield | ||
Proceeds from repurchase of equity | ||
BB yield | ||
| Debt | ||
Debt current | ||
Long-term debt | ||
Deferred revenue | ||
Other long-term liabilities | ||
Net debt | ||
| Cash flow | ||
Cash from operating activities | ||
CAPEX | ||
Cash from investing activities | ||
Cash from financing activities | ||
FCF | ||
| Balance | ||
Cash | ||
Long term investments | ||
Excess cash | ||
Stockholders' equity | ||
Invested Capital | ||
ROIC | ||
ROCE | ||
| EV | ||
Common stock shares outstanding | ||
Price | ||
Market cap | ||
EV | ||
EBITDA | ||
EV/EBITDA | ||
Interest | ||
Interest/NOPBT |